Morocco – Healthcare, Regulatory and Reimbursement Landscape

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

GlobalData, the industry analysis specialist, has released its latest report "Morocco – Healthcare, Regulatory and Reimbursement Landscape". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Morocco. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Morocco is an emerging player in the global pharmaceutical market. In 2019, Morocco's pharmaceutical industry exported around 11% of national production to Europe, America, Asia, and Africa, indicating the importance of this industry, which is ranked second among the African continents after South Africa in terms of quality. In terms of Moroccan Dirhams, the country’s pharmaceutical market increased from MAD 9.31B in 2015 to MAD 13.83B in 2020, at a Compound Annual Growth Rate (CAGR) of 8.2%. In the terms of US dollars, the Moroccan pharmaceutical market increased from $1.02B in 2015 to $1.49B in 2020, at a CAGR of 6.5%. Morocco’s stable political environment and strategic location in the Mediterranean region, which connects Sub-Saharan Africa, the Middle East, and Europe, are intended to alleviate country's pharmaceutical and healthcare industry in the next decade. The medical devices market in Morocco was valued at $270.2M in 2015, which decreased to $240.7M in 2020 at a negative CAGR of 2.3%. Morocco is progressively exploring to develop trade in medical devices and supplies with new partners, including Turkey, Brazil, Argentina, and several Far East countries, all of which can provide a similar quality of devices and supplies at lower costs. In 2018, the Moroccan Telemedicine Society (Société Marocaine de Télémédecine, SMT), in association with the Ministry of Health and Mohammed VI University of Health Sciences, launched a National Telemedicine Initiative with an aim to cover 160 rural municipalities and nearly 2 million population to create a significant health territory by 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Morocco, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: GSK, Pfizer, Novartis, Sanofi, and Sothema

Profiles and SWOT analyses of the major players in the medical device market: Roche Diagnostics, Abbott, Fresenius, Zimmer Biomet, and Air Liquide Healthcare

An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement landscape, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the Moroccan healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving the Moroccan healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Moroccan healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1 Table of Contents

2. Executive Summary

2.1 Executive Summary

2.2 Key Highlights – Facts about the Morocco Healthcare Market

2.3 Key Highlights: Healthcare Startups in Morocco

2.4 Key Events: Morocco Healthcare Industry, 2015-2021

2.5 Key Events: Morocco Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021

2.7 Key Events: Top Completed Deals by Value, 2020-2021

2.8 Country Profile, Morocco, 2020

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, Morocco

3.5 Pharmaceutical Market – Market Segments

3.6 Major Therapeutic Areas, Morocco

3.7 COVID-19 Epidemiology, Morocco

3.8 COVID-19 Impact and Developments, Government response to mitigate the impact of COVID-19 Morocco

3.9 COVID-19 Impact and Developments in the Healthcare Market, Morocco

3.10 COVID-19 Clinical Trials Landscape, Morocco

3.11 Pharmaceutical Market – Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Devices Market – Major Players

5. Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Morocco, 2019-2021

6.2 Deal Analysis: Medical Device Market, Morocco, 2020-2021

7. HealthTech Landscape

7.1 HealthTech Landscape, Morocco

7.2 HealthTech Deals Landscape, Morocco

7.3 Key HealthTech Deals, Morocco

7.4 Adoption of Technology in Healthcare, Morocco

7.5 Digital Health Regulations, Morocco

7.6 Digital Health: Benefits and Risks, Morocco

8. Market Access

8.1 Overview of Healthcare System, Morocco

8.2 Reimbursement Process, Morocco

8.3 Overview of Insurance Providers, Morocco

8.4 Out-of-Pocket Spending and Pharmaceutical Price Index, Morocco

8.5 Pricing Policies, Morocco

8.6 Regulatory Landscape, Morocco

8.6.1 Overview of Regulatory Agencies, Morocco

8.6.2 Marketing Authorization for Pharmaceutical Products, Morocco

8.6.3 Marketing Authorization for Biosimilars, Morocco

8.6.4 Marketing Authorization for Medical Devices, Morocco

8.6.5 Intellectual Property Rights, Patent, Morocco

8.6.6 Intellectual Property Rights, Trademark, Morocco

8.6.7 Clinical Trial Regulations, Morocco

8.6.8 Pharmaceutical Clinical Trials Landscape, Morocco

8.6.9 Medical Devices Clinical Trials Landscape, Morocco

8.6.10 Pharmacy License Regulations, Morocco

8.6.11 Pharmaceutical Advertising Regulations, Morocco

8.6.12 Labeling and Packaging Regulations, Morocco

9. Country Healthcare Landscape

9.1 Healthcare Policy Highlights, Morocco

9.2 Healthcare Facilities, Morocco

9.3 Life Expectancy and Immunization Rate, Morocco

9.4 Environmental Health, Morocco

9.5 Healthcare Personnel, Morocco

9.6 Disease Burden, Morocco

9.7 Healthcare Expenditure, Morocco

10. Trade Associations, Morocco

11. Trade Fairs, Morocco

12. Opportunities and Challenges

13. Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

Table

Table 1: List of Biosimilars Approved, Morocco, 2015-2019

Table 2: COVID-19 Indicators (Number of Cases), Morocco and Global, 2021

Table 3: COVID-19-Related Travel Restrictions, Morocco, 2020-2021

Table 4: Available COVID-19 Vaccines, Morocco, 2021

Table 5: Top COVID-19 Markets by Product Categories (Number of Available Marketed Products), Morocco, 2020-2021

Table 6: Legal Frameworks for e-Health, Morocco, 2019

Table 7: Patent Fees, Morocco, 2020

Table 8: Trademark Fees, Morocco, 2020

Table 9: Medical Devices Clinical Trials, Morocco, 2019-2021

Figures

Figure 1: Pharmaceutical Market, Morocco, Revenue ($B and MAD B), 2013-2020

Figure 2: Medical Device Market, Morocco, Revenue ($M), 2015-2020

Figure 3: Healthcare Start-Ups in Morocco, 2020

Figure 4: Country Profile, Morocco, 2020

Figure 5: Pharmaceutical Market, Morocco, Revenue ($B), 2015-2020

Figure 6: Pharmaceutical Market, Morocco, Revenue Forecast ($B), 2021-2025

Figure 7: Significant Events in the Evolution of the Pharmaceutical Industry, Morocco, 1960-2020

Figure 8: Pharmaceutical Exports ($M), Morocco, 2011-2020

Figure 9: Top Export Partners, Morocco, 2020

Figure 10: Pharmaceutical Imports ($M), Morocco, 2011-2020

Figure 11: Top Import Partners, Morocco, 2020

Figure 12: Pharmaceutical Distribution Channels, Morocco, 2019

Figure 13: Generics Market, Revenue (MAD B and $B), Morocco, 2015-2020

Figure 14: Generic Drug Consumption Volume (Millions of Units), Morocco, 2015-2020

Figure 15: OTC Market, Revenue (MAD M and $M), Morocco, 2015-2019

Figure 16: OTC Market, Million Number of Units, Morocco, 2016-2019

Figure 17: Biosimilars Market, Revenue (MAD M and $M), Morocco, 2015-2019

Figure 18: Major Pharmaceutical Products in the Market, Revenue in $M and MAD M), Morocco, 2019

Figure 19: Major Therapeutic Areas by Pharmaceutical Sales ($M), Morocco, 2017-2019

Figure 20: COVID-19 (Number of Cases), Morocco, 2020-2021

Figure 21: COVID-19 (Number of Deaths), Morocco, 2020-2021

Figure 22: COVID-19 Fiscal Stimulus Timeline, Morocco, 2020-2021

Figure 23: COVID-19 Vaccine Administration, Number of Vaccines administered, Morocco, 2021

Figure 24: Medical Devices Market, Morocco, Revenue ($M), 2013-2020

Figure 25: Medical Devices Market, Morocco, Revenue ($B) of Major Companies, 2020

Figure 26: Deal Value ($M), Pharmaceutical Market, Morocco, 2019-2021

Figure 27: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Morocco, 2019-2021

Figure 28: Deal Count, Pharmaceutical Market, Morocco, 2019-2021

Figure 29: Top Therapy Areas by Deal Value ($M), Pharmaceutical Market, Morocco, 2019-2021

Figure 30: Top Therapy Areas by Deal Count, Pharmaceutical Market, Morocco, 2019-2021

Figure 31: M&A Deals by Quarter, Pharmaceutical Market, Morocco, 2019-2021 (by Value and by Number)

Figure 32: M&A Deals, Medical Device Market, Morocco, 2020-2021 (by Value and by Number)

Figure 33: Deal Value and Deal Count, Quarterly, Medical Devices Market, Morocco, 2020-2021

Figure 34: Top Equipment Sectors, Medical Devices Market, Morocco, 2020-2021

(by Value and by Number)

Figure 35: Organizational Chart, National Commission for the Protection of Personal Data (CNDP), Morocco, 2021

Figure 36: Moroccan Patient-Centered Health Information System – Global Architecture, 2019

Figure 37: Deal Count (Number of Deals), HealthTech, Morocco, 2019-2021

Figure 38: Organization of Healthcare System, Morocco, 2019

Figure 39: Number of Drugs Reimbursable by the Compulsory Health Insurance (AMO) Morocco, 2011-2020

Figure 40: Reimbursement Process, Morocco, 2019

Figure 41: Distribution of Population across Health Insurance Schemes, Morocco, 2016

Figure 42: Out-of-Pocket Spending ($ per Capita), Morocco, 2011-2020

Figure 43: Change in Pharmaceutical Price Index (% Change Accumulated in the Year), Morocco, 2014-2020

Figure 44: Organizational Structure, Ministry of Health, Morocco, 2019

Figure 45: Marketing Authorization of Pharmaceutical Products, Morocco, 2020

Figure 46: Marketing Authorization of Biosimilars, Morocco, 2020

Figure 47: Patent Approval Process, Morocco, 2020

Figure 48: Trademark Approval Process, Morocco, 2020

Figure 49: Clinical Trial Approval Process, Morocco, 2020

Figure 50: Pharmaceutical Clinical Trials Count by Trial Status, Morocco, 2019-2021

Figure 51: Pharmaceutical Clinical Trials Count by Phase, Morocco, 2019-2021

Figure 52: Pharmaceutical Clinical Trials Count by Indication, Morocco, 2019-2021

Figure 53: Pharmaceutical Clinical trials by Trial Sponsors, Morocco, 2019-2021

Figure 54: Pharmacy Regulations, Morocco, 2019

Figure 55: Labelling and Packaging, Morocco, 2019

Figure 56: Number of Public Hospitals, Morocco, 2013-2020

Figure 57: Hospital Beds Density (per 10,000 Population), Morocco, 2013-2020

Figure 58: Life Expectancy at Birth (Years), Morocco, 2013-2020

Figure 59: Immunization Rate (% of Children Ages 12-23 Months), Morocco, 2013-2019

Figure 60: PM2.5 (µg per m3), Morocco, 2012-2020

Figure 61: CO2 Emissions (Mt of CO2), Morocco, 2012-2020

Figure 62: Number of Physicians, Morocco, 2013-2020

Figure 63: Number of Nurses, Morocco, 2013-2020

Figure 64: Number of Dentists, Morocco, 2013-2020

Figure 65: Number of Pharmacists, Morocco, 2013-2020

Figure 66: Major Causes of Mortality (per 100,000 population), Morocco, 2019

Figure 67: Major Causes of Male Mortality (per 100,000 population), Morocco, 2019

Figure 68: Major Causes of Female Mortality (per 100,000 population), Morocco, 2019

Figure 69: Disability-Adjusted Life Years by Major Disease (per 100,000 population), Morocco, 2019

Figure 70: Healthcare Expenditure as Percentage of GDP (%), Morocco, 2012-2020

Figure 71: Health Expenditure Share (% of Health Spending), Morocco, 2012-2020

Figure 72: Opportunities and Challenges

Frequently asked questions

Morocco – Healthcare, Regulatory and Reimbursement Landscape standard reports
Currency USD
$1,995

Can be used by individual purchaser only

$5,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Morocco – Healthcare, Regulatory and Reimbursement Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Morocco – Healthcare, Regulatory and Reimbursement Landscape in real time.

  • Access a live Morocco – Healthcare, Regulatory and Reimbursement Landscape dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.